Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.29 -0.15 (-2.33%) Market Cap: 950.41 Mil Enterprise Value: 791.33 Mil PE Ratio: 0 PB Ratio: 4.25 GF Score: 78/100

Q4 2021 Adaptive Biotechnologies Corp Earnings Call Transcript

Feb 15, 2022 / 09:30PM GMT
Release Date Price: $14.69 (+0.14%)
Operator

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Fourth Quarter and Full Year 2021 Earnings Results Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Ms. Karina Calzadilla, Investor Relations at Adaptive. Ms. Calzadilla, the floor is yours.

Karina Calzadilla
Adaptive Biotechnologies Corporation - VP of IR

Thank you, Chris, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies Fourth Quarter and Full Year 2021 Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive's financial results for the fourth quarter and full year of 2021. The press release is available at adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the Investors section in our corporate website.

During the call, management will make projections and other forward-looking statements within the meaning of federal securities laws regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot